Showing results (11-20 of 106) with videos related to
Sort By:
Pageof 11
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|June 4, 2016
Mathematical models of breast and ovarian cancersDana-Adriana Botesteanu, Stanley Lipkowitz, Jung-Min Lee, et al.Current Treatment Options in Oncology|April 13, 2018
Update on PARP Inhibitors in Breast CancerAlexandra S Zimmer, Mitchell Gillard, Stanley Lipkowitz, et al.Cancer Research|May 27, 2010
Cbl and human myeloid neoplasms: the Cbl oncogene comes of ageStephen C Kales, Philip E Ryan, Marion M Nau, et al.Trends in Biochemical Sciences|January 13, 2006
Regulating the regulator: negative regulation of Cbl ubiquitin ligasesPhilip E Ryan, Gareth C Davies, Marion M Nau, et al.Plos One|January 28, 2014
Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2AStephen C Kales, Marion M Nau, Anand S Merchant, et al.The Journal of Biological Chemistry|August 15, 2002
CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinasesIwona Szymkiewicz, Katarzyna Kowanetz, Philippe Soubeyran, et al.Current Oncology Reports|March 23, 2021
Rare Breast Cancer SubtypesSarah Jenkins, Megan E Kachur, Kamil Rechache, et al.Biology of the Cell|February 1, 2011
ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic traffickingHye-Young Yoon, Stephen C Kales, Ruibai Luo, et al.The Journal of Biological Chemistry|June 8, 2010
The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzymePhilip E Ryan, Nina Sivadasan-Nair, Marion M Nau, et al.Breast Cancer Research and Treatment|November 21, 2025
Chronic inflammatory diseases and survival among breast cancer patients in the U.S. military health systemJie Lin, Stanley Lipkowitz, Hai Hu, et al.Pageof 11